New Conference Announcement: Epigenetic Pathways and Human Disease Conference

We are pleased to share with you news of a very exciting new Epigenetics conference recently added to our 2020 diary. We are in no doubt that the meeting will prove very popular so early abstract submission and registration is strongly encouraged.

Epigenetic Pathways and Human Disease
30 Apr - 03 May 2020 | Crete
Chaired by Tony Kouzarides (The Gurdon Institute)

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Key Sessions
•    Chromatin regulatory pathways
•    RNA modification pathways
•    DNA modification pathways
•    Drug discovery

Tony Kouzarides is Professor of Cancer Biology at the University of Cambridge, Deputy Director of the Gurdon Institute and Director of the Milner Therapeutics Institute. He has forged an incredible career focused around Epigenetics and Cancer Research and we are very pleased to be working with him on this project.

This new meeting provides us with the opportunity to head to the beautiful Greek island of Crete. The Avra Imperial Hotel will play host to the conference and seamlessly blends first class conference facilities with stylish ambiance and creates an ideal environment in which to network, relax and allow for inspirational thinking away from the office or lab.

Tony Kouzarides